737 results found
Strains of A-beta aggregates in Alzheimer’s disease
Project Overview
The existence of different strains of misshapen proteins in the brains of Alzheimer’s disease (AD) patients is emerging as an obstacle to the development of effective treatments. Recent research has revealed that the proteins that accumulate in the brain during AD are reminiscent of prions, which cause rare brain diseases…
Project Complete
See the project and researchersDevelopment and validation of reagent kits for commercial high-throughput screening of PPI s and PPI inhibitors
Project Overview
Membrane proteins are biological molecules of incredible importance, playing diverse roles in many processes critical to life. Improper function of membrane proteins, however, is associated with many different diseases, such as diabetes, neurological disorders and cardiovascular diseases (among others). Membrane proteins are therefore of great therapeutic interest, and in fact…
Project Complete
See the project and researchersShARP: Screenable assays for RNA-binding proteins involved in brain disorders and diseases
Project Overview
Brain disorders such as autism, major depressive disorder and Alzheimer’s disease are among the greatest medical challenges of our era. Many drugs targeting the central nervous system (CNS) have been developed to modulate G protein-coupled receptors, ion channels or transporters with mitigated success. There remains a shortage of disease-relevant targets…
Project Complete
See the project and researchersA Patient-Derived hiPSC Neuronal Platform for Drug Discovery in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Project Overview
Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS) are two of the most common and devastating neurodegenerative diseases, affecting more than 2% of the population over the age of 65. However, a major hindrance in developing therapies for disorders of the brain has been limited access to human neurons from…
Project Complete
See the project and researchersNon Invasive Identification of Aβ Plaques in Human Retina for the Diagnosis of Alzheimer’s Disease
Project Overview
Currently, AD diagnosis can only be confirmed post-mortem by observing two AD hallmarks in the brain, β-amyloid (Aβ) plaques and tau strands. Diagnosing AD earlier in its course could dramatically transform the design of clinical trials to test new treatments. A team of researchers led by Dr. Jean-Paul Soucy of…